Recognition of Resveratrol by the Human Estrogen Receptor-Alpha: A Molecular Modeling Approach to Understand Its Biological Actions

Publisher Website
Google Scholar
Abstract
Objectives: Resveratrol (RSVL) is an edible phytoestrogen with multifaceted health benefits that may originate from binding to the estrogen receptors. Despite its structural similarity to the estrogen receptor-α (ERα) agonist diethylstilbestrol (DES), RSVL showed distinct biological profiles in estrogen-responsive biological systems. The molecular basis of such biological profiles has been undefined. Methods: We considered possible orientations for RSVL in ERα binding pocket. These conformations have been analyzed based on: (i) alignment with the key pharmacophoric elements of DES; (ii) computational energy of interaction, and (iii) pattern of accommodation at the ERα binding pocket. The characteristics of the most favored RSVL orientation have been compared with those of DES. Results: Both RSVL and DES interacted with the catalytic amino acid triad of the ERα pocket (His524, Arg394 and Glu 353). However, unlike the Erα agonists DES and estradiol (E2), RSVL formed three additional hydrogen bonds with Gly521 and Leu525, two paramount ligand recognition residues, and with Met343 at the ERα binding cavity. Lastly, RSVL displayed a more favorable energy of interaction with the ERα binding cavity. Conclusions: The present study suggests, for the first time, that RSVL is well recognized by the human ERα but in a manner distinct from the pure agonists DES and E2. These variations may well entail the unique biological responses of RSVL in ER-responsive systems.